The investigation of the effectiveness of ASA usage on corona virus

Phase 2

Recruiting

• Conditions: COVID-19 disease.; COVID-19; U07. 1

• Registration Number: IRCT20180205038626N7
• Lead Sponsor: Rasht University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

All patients admitted with a diagnosis of Covid 19 based on CT scan or PCR
Over 18 years

Exclusion Criteria

patients admitted to the ICU.
Patients with a history of ulcers and gastrointestinal problems.
Patients receiving aspirin.
patients with a history of thrombotic events such as heart attack or stroke or a history of atrial fibrillation, congestive heart failure, active bleeding or coagulation disorders such as thrombocytopenia.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Thromboembolic events. Timepoint: Thromboembolic events at the beginning of the study and 3 and 6 months later. Method of measurement: Clinical signs and laboratory tests.;Cardiovascular accidents. Timepoint: Cardiovascular accidents at the beginning of the study and 3 and 6 months later. Method of measurement: Electrocardiography, Echocardiography.;Brain accidents. Timepoint: Brain accidents at the beginning of the study and 3 and 6 months later. Method of measurement: CT scan.

Secondary Outcome Measures

Name	Time	Method
Death. Timepoint: 6 months later. Method of measurement: Phone call with the patient.